GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (FRA:GEKA) » Definitions » Shiller PE Ratio

Genomma Lab InternacionalB de CV (FRA:GEKA) Shiller PE Ratio : (As of May. 03, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Genomma Lab InternacionalB de CV Shiller PE Ratio Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Shiller PE Ratio Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.73 23.72 18.48 17.69 30.75

Genomma Lab InternacionalB de CV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.02 20.24 26.58 30.75 -

Competitive Comparison of Genomma Lab InternacionalB de CV's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Shiller PE Ratio falls into.


;
;

Genomma Lab InternacionalB de CV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Genomma Lab InternacionalB de CV's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Genomma Lab InternacionalB de CV's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.023/*
=

Current CPI (Mar. 2025) = .

Genomma Lab InternacionalB de CV Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.019 99.382 0.000
201509 0.009 100.112 0.000
201512 -0.090 101.588 0.000
201603 0.018 102.573 0.000
201606 -0.117 101.905 0.000
201609 0.021 103.084 0.000
201612 0.001 105.002 0.000
201703 0.021 108.063 0.000
201706 0.013 108.339 0.000
201709 0.010 109.628 0.000
201712 0.014 112.114 0.000
201803 0.016 113.505 0.000
201806 0.013 113.373 0.000
201809 0.010 115.130 0.000
201812 0.009 117.530 0.000
201903 0.011 118.050 0.000
201906 0.011 117.848 0.000
201909 0.010 118.581 0.000
201912 0.001 120.854 0.000
202003 0.014 121.885 0.000
202006 0.014 121.777 0.000
202009 0.015 123.341 0.000
202012 0.011 124.661 0.000
202103 0.013 127.574 0.000
202106 0.016 128.936 0.000
202109 0.016 130.742 0.000
202112 0.009 133.830 0.000
202203 0.015 137.082 0.000
202206 0.019 139.233 0.000
202209 0.020 142.116 0.000
202212 0.012 144.291 0.000
202303 0.018 146.472 0.000
202306 0.023 146.272 0.000
202309 0.019 148.446 0.000
202312 -0.003 151.017 0.000
202403 0.022 152.947 0.000
202406 0.034 153.551 0.000
202409 0.030 155.158 0.000
202412 0.022 155.158 0.000
202503 0.023 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Genomma Lab InternacionalB de CV  (FRA:GEKA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Genomma Lab InternacionalB de CV Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines